EMBECTA CORP. Restructuring Costs
EMBECTA CORP. (EMBC) reported Restructuring Costs of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-08-07
- EMBECTA CORP. restructuring costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- EMBECTA CORP. restructuring costs for the quarter ending 2026-03-31 was $100.00K, a 90.00% decline year-over-year.
- EMBECTA CORP. restructuring costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- EMBECTA CORP. restructuring costs for the quarter ending 2025-09-30 was $100.00K.
- EMBECTA CORP. restructuring costs for fiscal 2025 was $15.70M.
- EMBECTA CORP. restructuring costs for fiscal 2024 was $0.00.
- EMBECTA CORP. restructuring costs for fiscal 2023 was $0.00.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | $100.00K derived: sum of 2 quarters · filed 2026-08-07 | $100.00K 10-Q · filed 2026-08-07 | $200.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-05 | $100.00K 10-Q · filed 2026-05-05 | $200.00K derived: sum of 3 quarters · filed 2026-05-05 | $500.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-05 | $100.00K derived: sum of 2 quarters · filed 2026-02-05 | $400.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $400.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.40M derived: sum of 3 quarters · filed 2026-08-07 | $15.70M 10-K · filed 2025-11-25 |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-07 | $1.30M derived: sum of 2 quarters · filed 2026-08-07 | $15.60M 10-Q · filed 2026-08-07 | $15.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-05 | $15.30M 10-Q · filed 2026-05-05 | $15.30M derived: sum of 3 quarters · filed 2026-05-05 | $15.30M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $14.30M 10-Q · filed 2026-02-05 | $14.30M derived: sum of 2 quarters · filed 2026-02-05 | $14.30M derived: sum of 3 quarters · filed 2026-02-05 | $14.30M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $0.00 derived: sum of 2 quarters · filed 2025-11-25 | $0.00 derived: sum of 3 quarters · filed 2025-11-25 | $0.00 10-K · filed 2025-11-25 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 derived: sum of 2 quarters · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 10-Q · filed 2025-05-09 | ||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-06 | |||
| 2023-09-30 | $0.00 10-K · filed 2025-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |